MBX Biosciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Cash & Equivalents	75.29	49.35	30.52	24.21
Short-Term Investments	298.42	212.8	50.15	18.25
Cash & Short-Term Investments	373.71	262.15	80.68	42.46
Cash Growth	42.55%	224.94%	90.00%	-
Other Receivables	2.12	0.68	0.21	0.14
Receivables	2.12	0.68	0.21	0.14
Prepaid Expenses	4.85	3.65	2.45	1.52
Other Current Assets	0.86	0.8	0.13	0.08
Total Current Assets	381.54	267.29	83.47	44.21
Property, Plant & Equipment	3.22	1.2	0.67	0.84
Other Long-Term Assets	0.38	0.05	0.05	0.04
Total Assets	385.14	268.54	84.18	45.1
Accounts Payable	2.98	5.34	1.39	0.98
Accrued Expenses	12.35	5.55	2.38	2.32
Current Portion of Leases	0.17	0.17	0.15	0.14
Total Current Liabilities	15.5	11.05	3.93	3.43
Long-Term Leases	0.42	-	0.17	0.32
Other Long-Term Liabilities	0	0.04	0.19	0.07
Total Liabilities	15.92	11.09	4.29	3.82
Common Stock	0.01	0.01	0	0
Additional Paid-In Capital	593.41	394.89	3.05	0.41
Retained Earnings	-224.48	-137.51	-75.58	-43.02
Comprehensive Income & Other	0.29	0.06	0.06	0
Total Common Equity	369.22	257.44	-72.47	-42.61
Shareholders' Equity	369.22	257.44	79.89	41.27
Total Liabilities & Equity	385.14	268.54	84.18	45.1
Total Debt	0.6	0.17	0.32	0.46
Net Cash (Debt)	373.11	261.98	80.35	42
Net Cash Growth	42.42%	226.04%	91.31%	-
Net Cash Per Share	10.22	24.62	78.87	62.97
Filing Date Shares Outstanding	47.51	33.42	1.26	0.67
Total Common Shares Outstanding	44.93	33.42	1.26	0.67
Working Capital	366.04	256.24	79.54	40.78
Book Value Per Share	8.22	7.70	-57.65	-63.87
Tangible Book Value	369.22	257.44	-72.47	-42.61
Tangible Book Value Per Share	8.22	7.70	-57.65	-63.87
Machinery	1.27	1.11	0.24	0.23
Construction In Progress	1.62	-	0	-
Leasehold Improvements	0.52	0.39	0.37	0.35

Source: S&P Capital IQ. Standard template. Financial Sources.